Commonwealth Equity Services
BHVN

Commonwealth Equity Services’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Commonwealth Equity Services’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,512
Closed -$833K – 3881
2022
Q3 		$833K Sell
5,512
-259
-4% -$38.4K ﹤0.01% 2033
2022
Q2 		$840K Sell
5,771
-482
-8% -$61.6K ﹤0.01% 2038
2022
Q1 		$741K Buy
6,253
+397
+7% +$49.5K ﹤0.01% 2219
2021
Q4 		$807K Buy
5,856
+989
+20% +$126K ﹤0.01% 2145
2021
Q3 		$676K Sell
4,867
-133
-3% -$16.6K ﹤0.01% 2245
2021
Q2 		$485K Buy
5,000
+574
+13% +$46.6K ﹤0.01% 2497
2021
Q1 		$302K Sell
4,426
-36
-0.8% -$2.91K ﹤0.01% 2757
2020
Q4 		$382K Sell
4,462
-245
-5% -$20.8K ﹤0.01% 2355
2020
Q3 		$306K Buy
4,707
+188
+4% +$12.3K ﹤0.01% 2344
2020
Q2 		$330K Buy
+4,519
New +$240K ﹤0.01% 2207

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Commonwealth Equity Services's BHVN Position: Q4 2022 in Review

Commonwealth Equity Services sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 5,512 shares — an estimated $833K sold.

Commonwealth Equity Services first reported a position in BHVN in Q2 2020 and held it in 10 quarters. The position peaked at $840K in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Commonwealth Equity Services reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 5,512 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $833K.
  • Commonwealth Equity Services first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 10 quarters.
  • Commonwealth Equity Services's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $840K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.